[logo] Click here to return to home page...

  • International Press Descends on Framingham

    FRAMINGHAM, MA – Traffic slowed and snarled and parking was at a premium around the Framingham District Courthouse on Concord St. on Thursday, Feb. 16, 2006 as media and curious onlookers descended upon Framingham for the arraignment of Neil Entwistle on charges of the double homicide of his wife and daughter. Entwistle appeared in the Framingham Court because the district court issued the search and arrest warrant.

    Cameramen and their equipment had been camped out on the lawn, and TV satellite trucks staked out the parking lot in the days preceding the expected arrival of Entwistle from England.

    The parents and family of his wife attended the afternoon proceedings, the women carrying flowers. Entwistle barely looked at them.

    Framingham District Court Judge Robert Greco ordered Entwistle held without bail until his next day in court. Entwistle left the court in orange garb of a county jail inmate and faced the jeers of onlookers as well as a barrage of cameras and an International cadre of dozens of reporters as he left the courthouse for the Middlesex County Jail in Cambridge.

    Cameras and TV satellite trucks remained on the courthouse lawn and parking lot well into Thursday evening.

    ###

  • Framingham Public Schools Closed on Monday

    FRAMINGHAM, MA – Framingham Public Schools and offices will be closed on Monday, February 13, 2006 due to snow storm.

    ###

  • Clinical Trials at Metrowest Medical Center

    FRAMINGHAM, MA – The final phase of drug or medical therapy testing usually involves “clinical trials” — testing on human beings who volunteer to participate.

    The U.S. National Institute of Health closely monitors these trials and publishes information about such programs on their www.ClinicalTrials.gov website.

    Metrowest Medical Center, (the former “Framingham Union Hospital“), hosts several cancer related trials. A recent search of the site found several trials which are currently recruiting subjects for studies ranging from “observational” (no therapy or drug is administered, subjects are examined or monitored in hopes of discovering new information about a particular medical study), to clinical trials for as-yet (FDA) unapproved therapies or medicines.

    If you are interested in participating, it is suggested that you first visit the www.ClinicalTrials.com website and review the criteria for participants, then consult your doctor before contacting the recruiter for a particular trial.

    Below is a list of some of the trials which are currently recruiting in Framingham:

    Radiation Therapy With or Without Optional
    Tamoxifen in Treating Women With Ductal
    Carcinoma in Situ
    Contact: Teresa A. Van Buren, MD 508-383-1260
    (Trial ID#: NCT00003857)

    Radiation Therapy in Preventing CNS Metastases
    in Patients With Non-Small Cell Lung Cancer
    Contact: Allison H. Sacher, MD 508-383-1000
    (Trial ID#: NCT00048997)

    Anastrozole Compared With Tamoxifen After
    Lumpectomy in Treating Postmenopausal Women
    With Ductal Carcinoma in Situ
    Contact: Madhavi L. Venigalla, MD 508-383-1000
    (Trial ID#: NCT00053898)

    Radiation Therapy With Either Capecitabine or
    Fluorouracil Before Surgery in Treating Patients
    With Resectable Rectal Cancer
    Contact: Madhavi L. Venigalla, MD 508-383-1000
    (Trial ID#: NCT00058474)

    Suppression of Ovarian Function Plus Either Tamoxifen or
    Exemestane Compared With Tamoxifen Alone in Treating
    Premenopausal Women With Hormone-Responsive Breast Cancer
    Contact: Madhavi L. Venigalla, MD 508-383-1000
    (Trial ID#: NCT00066690)

    Comparison of Combination Chemotherapy Regimens
    With or Without Cetuximab in Treating Patients Who
    Have Undergone Surgery For Stage III Colon Cancer
    Contact: Madhavi L. Venigalla, MD 508-383-1000
    (Trial ID#: NCT00079274)

    Combination Chemotherapy in Treating Women Who Have
    Undergone Surgery for Node-Positive Breast Cancer
    Contact: Madhavi L. Venigalla, MD 508-383-1000
    (Trial ID#: NCT00093795)

    Docetaxel and Prednisone With or Without Bevacizumab
    in Treating Patients With Prostate Cancer That Did Not
    Respond to Hormone Therapy
    Contact: John G. Krikorian 508-383-1000
    (Trial ID#: NCT00110214)

    For more information visit: www.clinicaltrials.gov

    ###

Template Name: Archive